The Role of Nutraceuticals in Statin Intolerant Patients

International Lipid Expert Panel (ILEP)

Research output: Contribution to journalReview article

96 Citations (Scopus)

Abstract

Statins are the most common drugs administered for patients with cardiovascular disease. However, due to statin-associated muscle symptoms, adherence to statin therapy is challenging in clinical practice. Certain nutraceuticals, such as red yeast rice, bergamot, berberine, artichoke, soluble fiber, and plant sterols and stanols alone or in combination with each other, as well as with ezetimibe, might be considered as an alternative or add-on therapy to statins, although there is still insufficient evidence available with respect to long-term safety and effectiveness on cardiovascular disease prevention and treatment. These nutraceuticals could exert significant lipid-lowering activity and might present multiple non–lipid-lowering actions, including improvement of endothelial dysfunction and arterial stiffness, as well as anti-inflammatory and antioxidative properties. The aim of this expert opinion paper is to provide the first attempt at recommendation on the management of statin intolerance through the use of nutraceuticals with particular attention on those with effective low-density lipoprotein cholesterol reduction.

Original languageEnglish
Pages (from-to)96-118
Number of pages23
JournalJournal of the American College of Cardiology
Volume72
Issue number1
DOIs
Publication statusPublished - 3 Jul 2018

Fingerprint Dive into the research topics of 'The Role of Nutraceuticals in Statin Intolerant Patients'. Together they form a unique fingerprint.

Cite this